Browsing Institutt for klinisk medisin by Author "Raab, Marc S."

Now showing items 1-1 of 1

  • Cobimetinib alone and plus venetoclax with/without atezolizumab in patients with relapsed/refractory multiple myeloma 
    Schjesvold, Fredrik Hellem; Paiva, Bruno; Ribrag, Vincent; Rodriguez-Otero, Paula; San-Miguel, Jesus F.; Robak, Pawel; Hansson, Markus; Onishi, Maika; Hamidi, Habib; Malhi, Vikram; Dail, Monique; Javery, Apurva; Ku, Grace; Raab, Marc S. (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2022)
    Introduction Mitogen-activated protein kinase pathway mutations are present in >50% of patients with relapsed/refractory (R/R) multiple myeloma (MM). MEK inhibitors show limited single-agent activity in R/R MM; combination ...